BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28076755)

  • 1. RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells.
    King HO; Brend T; Payne HL; Wright A; Ward TA; Patel K; Egnuni T; Stead LF; Patel A; Wurdak H; Short SC
    Stem Cell Reports; 2017 Jan; 8(1):125-139. PubMed ID: 28076755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Cycle Changes after Glioblastoma Stem Cell Irradiation: The Major Role of RAD51.
    Tachon G; Cortes U; Guichet PO; Rivet P; Balbous A; Masliantsev K; Berger A; Boissonnade O; Wager M; Karayan-Tapon L
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30282933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-quadruplex ligand RHPS4 radiosensitizes glioblastoma xenograft in vivo through a differential targeting of bulky differentiated- and stem-cancer cells.
    Berardinelli F; Tanori M; Muoio D; Buccarelli M; di Masi A; Leone S; Ricci-Vitiani L; Pallini R; Mancuso M; Antoccia A
    J Exp Clin Cancer Res; 2019 Jul; 38(1):311. PubMed ID: 31311580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rad51 inhibition is an effective means of targeting DNA repair in glioma models and CD133+ tumor-derived cells.
    Short SC; Giampieri S; Worku M; Alcaide-German M; Sioftanos G; Bourne S; Lio KI; Shaked-Rabi M; Martindale C
    Neuro Oncol; 2011 May; 13(5):487-99. PubMed ID: 21363882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiosensitizing effect of RAD51 inhibition in glioblastoma stem-like cells.
    Balbous A; Cortes U; Guilloteau K; Rivet P; Pinel B; Duchesne M; Godet J; Boissonnade O; Wager M; Bensadoun RJ; Chomel JC; Karayan-Tapon L
    BMC Cancer; 2016 Aug; 16():604. PubMed ID: 27495836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Essential role of METTL3-mediated m
    Visvanathan A; Patil V; Arora A; Hegde AS; Arivazhagan A; Santosh V; Somasundaram K
    Oncogene; 2018 Jan; 37(4):522-533. PubMed ID: 28991227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133+ glioblastoma stem-like cells are radiosensitive with a defective DNA damage response compared with established cell lines.
    McCord AM; Jamal M; Williams ES; Camphausen K; Tofilon PJ
    Clin Cancer Res; 2009 Aug; 15(16):5145-53. PubMed ID: 19671863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
    Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
    Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA repair after irradiation in glioma cells and normal human astrocytes.
    Short SC; Martindale C; Bourne S; Brand G; Woodcock M; Johnston P
    Neuro Oncol; 2007 Oct; 9(4):404-11. PubMed ID: 17704360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TAS-116, a Novel Hsp90 Inhibitor, Selectively Enhances Radiosensitivity of Human Cancer Cells to X-rays and Carbon Ion Radiation.
    Lee Y; Sunada S; Hirakawa H; Fujimori A; Nickoloff JA; Okayasu R
    Mol Cancer Ther; 2017 Jan; 16(1):16-24. PubMed ID: 28062703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation.
    Saydam O; Saydam N; Glauser DL; Pruschy M; Dinh-Van V; Hilbe M; Jacobs AH; Ackermann M; Fraefel C
    Gene Ther; 2007 Aug; 14(15):1143-51. PubMed ID: 17495946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton beam radiation induces DNA damage and cell apoptosis in glioma stem cells through reactive oxygen species.
    Alan Mitteer R; Wang Y; Shah J; Gordon S; Fager M; Butter PP; Jun Kim H; Guardiola-Salmeron C; Carabe-Fernandez A; Fan Y
    Sci Rep; 2015 Sep; 5():13961. PubMed ID: 26354413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
    Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
    Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells.
    Yun HS; Lee J; Kil WJ; Kramp TR; Tofilon PJ; Camphausen K
    Mol Cancer Ther; 2021 Sep; 20(9):1672-1679. PubMed ID: 34158343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperthermia Sensitizes Glioma Stem-like Cells to Radiation by Inhibiting AKT Signaling.
    Man J; Shoemake JD; Ma T; Rizzo AE; Godley AR; Wu Q; Mohammadi AM; Bao S; Rich JN; Yu JS
    Cancer Res; 2015 Apr; 75(8):1760-9. PubMed ID: 25712125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting DNA double strand break repair with hyperthermia and DNA-PKcs inhibition to enhance the effect of radiation treatment.
    van Oorschot B; Granata G; Di Franco S; Ten Cate R; Rodermond HM; Todaro M; Medema JP; Franken NA
    Oncotarget; 2016 Oct; 7(40):65504-65513. PubMed ID: 27602767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel long non-coding RNA TALNEC2, regulates tumor cell growth and the stemness and radiation response of glioma stem cells.
    Brodie S; Lee HK; Jiang W; Cazacu S; Xiang C; Poisson LM; Datta I; Kalkanis S; Ginsberg D; Brodie C
    Oncotarget; 2017 May; 8(19):31785-31801. PubMed ID: 28423669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
    Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
    Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal DNA-PK activation drives genomic instability and therapy resistance in glioma stem cells.
    Wang Y; Xu H; Liu T; Huang M; Butter PP; Li C; Zhang L; Kao GD; Gong Y; Maity A; Koumenis C; Fan Y
    JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.